---
title: 삼천당제약 (000250)
categories:
- KOSDAQ
- Q:제약
- 고PER
- 고PBR
---
| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 64,100 | <span style="color: blue">-4.6<small>%</small></span> | Q:제약 | 241.9 | 8.1 | - |

<!-- more -->

<br>
> **최근 7일 DART 신규 공시**<a id="dart"></a>


| **일자** | **보고서명** |
| :--------- | :----------- |
| 01-26 | [풍문또는보도에대한해명(미확정)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240126900804){:target="_blank"} |

<br>
> **주가 흐름**<a id="price"></a>

![000250](/stock/images/000250.png)

> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 64,100 | <span style="color: blue">-4.6<small>%</small></span> | <span style="color: blue">-8.8<small>%</small></span> | <span style="color: blue">-18.9<small>%</small></span> | <span style="color: blue">-5.9<small>%</small></span> | <span style="color: blue">-5.0<small>%</small></span> |
| **1년** | **표준편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: red">33.3<small>%</small></span> | 72.8<small>%</small> | 0.46 | -49.0<small>%</small> | -23.7<small>%</small> | 0.7 |

<br>
> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![000250](/stock/images/000250_tech.png)

| **기술 지표** | **1년** | **표준편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 33.3<small>%</small> | 72.8<small>%</small> | 0.46 | -49.0<small>%</small> | -23.7<small>%</small> |
| SMA (5, 20)<small>[^fn_tech_metric_sma]</small> | 14.6<small>%</small> | 49.6<small>%</small> | 0.29 | -32.5<small>%</small> | -18.8<small>%</small> |
| SMA (20, 60)<small>[^fn_tech_metric_sma]</small> | 15.2<small>%</small> | 60.3<small>%</small> | 0.25 | -45.4<small>%</small> | -25.6<small>%</small> |
| MACD (12, 26, 9)<small>[^fn_tech_metric_macd]</small> | 26.6<small>%</small> | 57.2<small>%</small> | 0.47 | -33.5<small>%</small> | -17.7<small>%</small> |
| C_SMA (5, 20, 60)<small>[^fn_tech_metric_c_sma]</small> | 12.3<small>%</small> | 45.7<small>%</small> | 0.27 | -30.1<small>%</small> | -20.5<small>%</small> |

<br>
> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| Q:제약 | 241.9 | 8.1 | - | 고PER, 고PBR |

<br>
> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![000250](/stock/images/000250_corr.png)

|    | [세방전지](/004490/) | [레인보우로보틱스](/277810/) | [에스피지](/058610/) |
| :- | :------------------------------------- | :------------------------------------- | :--------------------------------------|
|    | [알테오젠](/196170/) | [솔브레인홀딩스](/036830/) | [에코프로머티](/450080/) |
|    | [한올바이오파마](/009420/) | [엠로](/058970/) | [DB손해보험](/005830/) |

<br>
> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![000250](/stock/images/000250_2x.png)

---
{% include commons/footnotes.md %}